Xudong Ni
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2026
Evolving therapies, persistent gaps: a real-world look at survival trends in metastatic prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: February 04, 2026
Bond-Valence-Driven Model for Highest Infrared-Active Optical Phonon Frequency in Complex Oxides.
Journal: The journal of physical chemistry letters
Published: December 29, 2025
Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy.
Journal: Med (New York, N.Y.)
Published: December 04, 2025
Integrating China's Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose.
Journal: Cancer discovery
Published: November 30, 2025
68Ga-MY6349 PET/CT-guided TROP2-targeted therapy in mCRPC.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 23, 2025
Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS.
Journal: The Journal of urology
Published: March 25, 2025
Homologous recombination repair gene alteration is strongly associated with more prostate-specific membrane antigen-positive metastases in newly diagnosed hormone-sensitive prostate cancer with ≤5 conventional imaging defined distant metastases.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 03, 2025
Development and validation of a machine learning-based risk model for metastatic disease in nmCRPC patients: a tumor marker prognostic study.
Journal: International journal of surgery (London, England)
Published: August 09, 2024
From biology to the clinic - exploring liver metastasis in prostate cancer.
Journal: Nature reviews. Urology
Published: March 22, 2024
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy.
Journal: BMC cancer
Published: December 15, 2023
Authors' Reply to the Letter to the Editor by Nguyen et al.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 07, 2023
Last Updated: 09/26/2026